Andrew Douglas Pearlman, MD | |
1324 Motor Pkwy, Islandia, NY 11749-5262 | |
(631) 963-7700 | |
Not Available |
Full Name | Andrew Douglas Pearlman |
---|---|
Gender | Male |
Speciality | Radiation Oncology |
Experience | 37 Years |
Location | 1324 Motor Pkwy, Islandia, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386733319 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Integrated Medical Professionals Pllc | 6406868462 | 85 |
News Archive
Afraxis, a San Diego-based biotechnology company developing drugs to treat rare genetic diseases through the modulation of p21-activated kinase (PAK), announced today that it has been selected to participate in the National Institutes of Health's (NIH) Therapeutics for Rare and Neglected Disease (TRND) Program.
Only half of brain cancers actually start in the brain. The rest - as in the case of former president Jimmy Carter - are metastatic tumors from cancer that originated elsewhere in the body.
DARA BioSciences announced today grant approvals by the Internal Revenue Service under the Patient Protection and Affordable Care Act of 2010 for KRN5500 and DB959 in the amount of approximately $500,000 for the calendar year 2009.
New research carried out by City data scientist, Dr. Andrea Baronchelli, and colleagues, into the dark web marketplace (DWM) trade in products related to COVID-19, has revealed the need for the continuous monitoring of dark web marketplaces (DWMs), especially in light of the current shortage and availability of coronavirus vaccines.
› Verified 6 days ago
Entity Name | Integrated Medical Professionals Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346203536 PECOS PAC ID: 6406868462 Enrollment ID: O20060613000088 |
News Archive
Afraxis, a San Diego-based biotechnology company developing drugs to treat rare genetic diseases through the modulation of p21-activated kinase (PAK), announced today that it has been selected to participate in the National Institutes of Health's (NIH) Therapeutics for Rare and Neglected Disease (TRND) Program.
Only half of brain cancers actually start in the brain. The rest - as in the case of former president Jimmy Carter - are metastatic tumors from cancer that originated elsewhere in the body.
DARA BioSciences announced today grant approvals by the Internal Revenue Service under the Patient Protection and Affordable Care Act of 2010 for KRN5500 and DB959 in the amount of approximately $500,000 for the calendar year 2009.
New research carried out by City data scientist, Dr. Andrea Baronchelli, and colleagues, into the dark web marketplace (DWM) trade in products related to COVID-19, has revealed the need for the continuous monitoring of dark web marketplaces (DWMs), especially in light of the current shortage and availability of coronavirus vaccines.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Andrew Douglas Pearlman, MD 532 Broadhollow Rd, Suite 142, Melville, NY 11747-3672 Ph: (516) 931-0041 | Andrew Douglas Pearlman, MD 1324 Motor Pkwy, Islandia, NY 11749-5262 Ph: (631) 963-7700 |
News Archive
Afraxis, a San Diego-based biotechnology company developing drugs to treat rare genetic diseases through the modulation of p21-activated kinase (PAK), announced today that it has been selected to participate in the National Institutes of Health's (NIH) Therapeutics for Rare and Neglected Disease (TRND) Program.
Only half of brain cancers actually start in the brain. The rest - as in the case of former president Jimmy Carter - are metastatic tumors from cancer that originated elsewhere in the body.
DARA BioSciences announced today grant approvals by the Internal Revenue Service under the Patient Protection and Affordable Care Act of 2010 for KRN5500 and DB959 in the amount of approximately $500,000 for the calendar year 2009.
New research carried out by City data scientist, Dr. Andrea Baronchelli, and colleagues, into the dark web marketplace (DWM) trade in products related to COVID-19, has revealed the need for the continuous monitoring of dark web marketplaces (DWMs), especially in light of the current shortage and availability of coronavirus vaccines.
› Verified 6 days ago
Eduard Kagan, MD Radiology Medicare: Medicare Enrolled Practice Location: 1324 Motor Pkwy, Islandia, NY 11749 Phone: 631-963-7700 Fax: 631-232-0147 | |
Dr. Jigna Desai Jhaveri, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1324 Motor Pkwy, Islandia, NY 11749 Phone: 631-963-7700 Fax: 631-232-0147 |